Bayer stock: UBS keeps EUR 62.00 target for Bayer stock
Published on 10/16/2026 at 17:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and quarterly metrics
- UBS maintained a EUR 62.00 Bayer price target in a study dated October 14, 2026.
- Bayer generated EUR 10.87 billion in second-quarter 2026 revenue, up 1.24 percent year over year.
- Bayer stock costs EUR 44.81 at 10:27 a.m. CEST on October 16, 2026, up 0.90 percent versus the Xetra close of October 15, 2026.
- Bayer had a EUR 43.7 billion market capitalization and a P/E ratio of minus 25.27 on October 16, 2026.
UBS maintained its Buy rating on Bayer and a EUR 62.00 price target in a study dated October 14, 2026, according to finanzen.at. Against the Tradegate quote of EUR 44.81 on October 16, 2026, the target is 38.36 percent above the price. The Tradegate quote stood at EUR 44.81 on October 16, 2026 at 10:27 a.m. CEST, up 0.90 percent versus the Xetra close of October 15, 2026.
Second-quarter revenue grew 1.24 percent
Bayer generated EUR 10.87 billion in second-quarter 2026 revenue, up 1.24 percent from EUR 10.74 billion in the second quarter of 2025, according to Finanztrends. The figure gives the upcoming report a concrete comparison point as investors assess the balance between Bayer's pharmaceutical portfolio and Crop Science business.
The range leaves 16.90 percent to the high
The Tradegate price was 16.90 percent below Bayer's 52-week high of EUR 53.92 and 73.82 percent above its EUR 25.78 low on October 16, 2026. Bayer was up 22.70 percent year to date, according to finanzen.at.
Valuation before November 3
Bayer had a market capitalization of EUR 43.7 billion and a P/E ratio of minus 25.27 on October 16, 2026. Bayer's third-quarter results are scheduled for November 3, 2026, with publication at 7:30 a.m. CET, according to Bayer.
Comparison with peers
Bayer: plus 0.90 percent, P/E minus 25.27, market capitalization EUR 43.7 billion
BASF (Xetra, EUR): plus 1.33 percent, P/E 8.02, market capitalization EUR 46.0 billion
Merck (Xetra, EUR): plus 0.73 percent, P/E 26.48, market capitalization EUR 62.7 billion
Tradegate quote versus Xetra
The Tradegate quote stood at EUR 44.81 on October 16, 2026 at 10:27 a.m. CEST, 0.90 percent above the Xetra close of EUR 44.41 on October 15, 2026.
Bayer market snapshot
- Company: Bayer Aktiengesellschaft
- ISIN: DE000BAY0017
- WKN: BAY001
- Ticker: BAYN
- Primary exchange: Xetra
- Price Tradegate (as of October 16, 2026, 10:27 a.m. CEST): EUR 44.81
- Change versus Xetra close: plus 0.90 percent
- Xetra close (October 15, 2026): EUR 44.41
- Market capitalization: EUR 43.7 billion (as of October 16, 2026)
- 52-week range: EUR 25.78-53.92 (as of October 16, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
- Index membership: DAX
Market context: Market report DAX.
